Expert in FDA Regulatory Expert Witness Regarding Medical Devices, Drugs, Software and Data Integrity
Expert ID: 732460 Maryland, USA
1) What did the company know and when did they know it? 2) What should the company have known and when should they have known it? 3) What should the company have done and when should they have done it? Contributed as an FDA regulatory expert witness in cases involving death and injury caused by drugs and medical devices, size of monetary awards, insurance claims, patents and merger contracts.
Expert may consult nationally and internationally, and is also local to the following cities: Washington, D.C.
|Year: 1981||Degree: PhD||Subject: Physiology||Institution: University of Georgia|
|Year: 1976||Degree: MS||Subject: Physilogy||Institution: University of Maryland|
|Year: 1973||Degree: BS||Subject: Zoology||Institution: Univerity of Iowa|
|Years: 1994 to Present||Employer: Undisclosed||Title: President||Department:||Responsibilities: Expert serves as an FDA compliance expert, trainer, SAS programmer, statistician, technical writer, and auditor. He utilizes his authority on auditing, writing NDAs, PMAs, protocols and SOPs. He also employs his expertise in validation and 21 CFR Part 11 compliance.|
|Years: 1992 to 1994||Employer: Food and Drug Administration||Title: Drug Reviewer||Department:||Responsibilities: Managed the drug review process. Instructed firms on how to proceed with drug approval. Summarized outstanding problems and issues with protocols and studies, and determined if deficiencies were adequately addressed. Reviewed statistical methodology of studies. Authored all written communication to the sponsoring firm and integrated comments from other reviewers. Developed techniques to evaluate submission data quality.|
|Years: 1989 to 1992||Employer: Marriott Hotels||Title: Director of hotel Customer Information systems||Department: Marketing||Responsibilities: Managed a team of 25 programmers responsible for building the system supporting Marriott Hotel’s Rewards program|
|Years: 1992 to 1994||Agency: Food and Drug Administration||Role: Drug Reviewer||Description: Expert managed the drug review process. He instructed firms on how to proceed with drug approval. He also summarized outstanding problems and issues with protocols and studies, and determined if deficiencies were adequately addressed. Expert reviewed statistical methodology of studies. He authored all written communication to the sponsoring firm and integrated comments from other reviewers. He developed techniques to evaluate submission data quality.|
|Expert Witness Experience|
|He is an expert in searching the medical literature for all safety-related information about an FDA-regulated product. His specialties include building timelines to describe how and when the knowledge base about a product increased, and to explain the development of new conclusions about a product’s safety. He is skilled at answering three questions: What did the company know and when did they know it? What should the company have known and when should they have known it? What should the company have done and when should they have done it?
Expert has supported plaintiff attorneys with FDA regulatory information and insight in cases involving Actos, Fentanyl Sulindac and defective hip implants.
|Training / Seminars|
| Expert has developed training for scientists in computerization and analysis of data. He created and taught instructor-led classes in SAS validation and FDA compliance. He wrote and taught over 40 different audio conference classes on a wide variety of FDA regulatory, technical and compliance topics attended by over 50,000 people from FDA regulated companies. He has taught FDA compliance to students in India using Skype.
Fields of Expertise
Food and Drug Administration compliance, Food and Drug Administration regulation, Food and Drug Administration validation, Food and Drug Administration, Food and Drug Administration drug packaging regulation, FDA medical device regulation, biomedical device, Food and Drug Administration new drug code, expert witness, medical software quality assurance, software validation, FDA electronic record, FDA software, FDA software validation, FDA 21CFR 11 compliance